{"nctId":"NCT03686384","briefTitle":"SVT-15652 Otic Solution for the Treatment of Otomycosis","startDateStruct":{"date":"2020-02-27","type":"ACTUAL"},"conditions":["Otomycosis"],"count":217,"armGroups":[{"label":"SVT-15652","type":"EXPERIMENTAL","interventionNames":["Drug: SVT-15652"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"SVT-15652","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Main Inclusion Criteria:\n\n* At least 18 years of age\n* Clinical diagnosis of otomycosis in one or both ears, where topical treatment is indicated.\n* Signs/symptoms of pruritus, otalgia and ear fullness.\n* Debris or drainage clinically consistent with fungal infection.\n\nMain Exclusion Criteria:\n\n* Known bacterial otitis externa or malignant otitis externa.\n* Tympanic perforation, tympanostomy tubes inserted and post mastoid surgery.\n* Structural ear anomalies which may difficult the evaluation of the therapeutic response.\n* Uncontrolled diabetes mellitus.\n* Any infection requiring systemic antimicrobial or systemic antifungal therapy.\n* Concomitant medicines that may interfere with the study evaluations.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Therapeutical Cure (Clinical and Mycological Cure)","description":"Number and percentage of subjects with therapeutic cure","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":134},"commonTop":["Headache","Ear pain"]}}}